Peiliang Wang

Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study

Peiliang Wang, Xiaozhuang Fang, Tianwen Yin et al. · Frontiers in Oncology · 2021 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases

Aijie Li, Xiangkui Mu, Kewen He et al. · Future Oncology · 2020 · 39 citations

Medicine, Immunology, Oncology +16

Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients

Xin Wang, Zongxing Zhao, Peiliang Wang et al. · Frontiers in Oncology · 2020 · 34 citations · Full text

Medicine, Oncology, Radiation Oncology +17

CD103+CD8+ T lymphocytes in non-small cell lung cancer are phenotypically and functionally primed to respond to PD-1 blockade

Peiliang Wang, Bing Huang, Yi Gao et al. · Cellular Immunology · 2018 · 24 citations

Life Sciences, Immunology, Oncology +14

Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition

Yikun Li, Peiliang Wang, Junhao Xu et al. · OncoImmunology · 2024 · 24 citations · Full text

Medicine, Oncology, Radiology +17